Signal Fading: 2 Windows Hit, Third Still Open
Schwab U.S. Broad Market ETF at week 6 of the BUY: 2 management windows already hit, breakeven stop in place, signal strength at 27 out of 100 and fading. The operational picture calls for management, not reinforcement.
Starbucks at the window: 1st target hit, focus shifts to week eight
The Starbucks Long is at week 6: the model's first target area was already hit last week. The stop is at breakeven, risk is zeroed out. The signal holds, but strength at 66 out of 100 is not expanding.
Sanofi SA: second-week sell signal, strength at the bottom of the ranking
Sanofi SA carries a second-week sell signal, but ranks last among EU-UK sell signals with strength at 2 out of 100. Quality band flags trading not recommended: elevated-risk opening per our model.
Safran SA: weak bearish pressure in a high-risk setup
Safran SA is in the third week of a sell signal with fading strength at 24 out of 100. Our model flags trading as not recommended: current conditions do not justify opening a short position at this stage.
Recursion Pharmaceuticals: fresh sell signal in a high-risk setup
Recursion Pharmaceuticals gets a fresh weekly sell signal in week 1. Signal strength is low at 22 out of 100, and our model flags elevated-risk conditions: trading not recommended.
RTX Corporation: fading strength, adverse confirmation week
Sell signal on RTX Corporation at week 7, with signal strength at 12 out of 100 and fading. Our model flags elevated-risk conditions. The confirmation week closed bullish, suggesting an exit from the position.